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Phosphorylation of the WH2 
domain in yeast Las17/
WASP regulates G‑actin 
binding and protein function 
during endocytosis
J. J. Tyler1,2, I. I. Smaczynska‑de Rooij1,2, L. Abugharsa1,2, J. S. Palmer1, L. P. Hancock1, 
E. G. Allwood1 & K. R. Ayscough1*
Actin nucleation is the key rate limiting step in the process of actin polymerization, and tight 
regulation of this process is critical to ensure actin filaments form only at specific times and at defined 
regions of the cell. WH2 domains are short sequence motifs found in many different actin binding 
proteins including WASP family proteins which regulate the actin nucleating complex Arp2/3. In 
this study we reveal a phosphorylation site, Serine 554, within the WH2 domain of the yeast WASP 
homologue Las17. Both phosphorylation and a phospho‑mimetic mutation reduce actin monomer 
binding affinity while an alanine mutation, generated to mimic the non‑phosphorylated state, 
increases actin binding affinity. The effect of these mutations on the Las17‑dependent process of 
endocytosis in vivo was analysed and leads us to propose that switching of Las17 phosphorylation 
states may allow progression through distinct phases of endocytosis from site assembly through to 
the final scission stage. While the study is focused on Las17, the sole WASP family protein in yeast, our 
results have broad implications for our understanding of how a key residue in this conserved motif can 
underpin the many different actin regulatory roles with which WH2 domains have been associated.
The WH2 motif is an abundant and versatile G-actin binding sequence found in a wide array of actin binding 
 proteins1,2. WH2 motifs are characterised by an N-terminal amphipathic helix and a C terminal LKKV  motif1. 
The N-terminal helix binds to actin at the hydrophobic cleft at the barbed end of a monomer whilst the LKKV 
motif extends along the monomer towards the pointed end. The interaction with the barbed end blocks addition 
of the WH2 bound monomer to the pointed end of a filament, potentially enhancing directional  polymerisation1.
WH2 motifs are intrinsically disordered regions (IDRs), which adopt multiple conformations in solution and 
only adopt a defined structure upon binding to  actin3. Like other IDRs the lower folding constraints allow for 
large variation in sequence. This, as well as the dynamic nature of the interaction between the WH2 motif and 
the actin monomer, helps to explain the broad array of divergent actin related processes in which WH2 motifs 
are implicated. These include: nucleation, filament severing, monomer sequestration, monomer delivery and 
regulation of barbed-end  dynamics2,4–8. Despite the range of associated functions, multiple crystal structures 
show different WH2 motifs binding to actin in an almost identical manner, making the source of the functional 
variation unclear. However, some reports reveal that small changes in sequence can result in significant changes 
in activity. For example, mutation of residues within the amphipathic helix of the third WH2 motif of Spire have 
been shown to markedly reduce nucleation, without having a large effect on the strength of G-actin  binding9. 
Similarly, the polar nature of the C-terminus of the helix in the first WH2 motif of the nucleator Cobl has been 
shown to be important for its nucleation  activity8.
In terms of a role in actin filament nucleation, in some proteins, for example those of the WASP family, WH2 
domains are located adjacent to sites that also bind Arp2/3. In other proteins WH2 domains are found in pairs 
or tandem arrays that have the potential to bind multiple actin monomers, and this binding has been proposed 
to support actin nucleation independently of Arp2/36,10–13. The ability of the WH2 domain to bind G-actin is 
critical for Arp2/3-mediated actin nucleation and subsequent polymerization. However, the balance between 
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binding of G-actin, and the subsequent ability to release this monomer to be incorporated into a growing fila-
ment is likely to be a key aspect of this mechanism, and one that has received relatively little  attention14. It might 
be expected that regulating the affinity of WH2 binding for actin has the potential to play a critical role in rate of 
nucleation and onset of filament growth. The nucleation promotion activity of WASP family proteins is regulated 
by a number of mechanisms in vivo. Phosphorylation within the C-terminal intrinsically disordered region e.g. 
on WASP/N-WASP S483,S484/S484,S485 has been  detected15, though to date phosphorylation has mostly been 
identified and considered in terms of its potential to promote nucleation by disruption of the auto-inhibitory 
interface between the C-terminal CA region and the GTPase binding CRIB  domain3,16,17.
Las17 is the only WASP family protein in the budding yeast Saccharomyces cerevisiae. It is the primary acti-
vator of Arp2/3-driven actin nucleation, and is required for membrane invagination during  endocytosis18–20. 
Las17 has a similar domain structure to mammalian WASP having an N-terminal WH1 domain, a proline rich 
region and a C-terminal WH2 G-actin binding motif adjacent to a central and acidic (CA) region that binds 
Arp2/3. Las17 does not however contain a GTPase binding region so is not considered to be regulated by binding 
of rho-family GTPase proteins. The yeast protein Vrp1 (homologue of mammalian WASP interacting protein, 
WIP) also contains WH2 domains and is proposed to act with Las17 during later stages of  endocytosis21. The 
prevailing model of Arp2/3-driven actin nucleation and polymerization in cells requires binding of G-actin by 
the WH2 domain and delivery of this monomer to the actin pre-nucleus formed by Arp2 and Arp3 within the 
Arp2/3 complex. Central to the model, is that the WH2 domains both bind actin monomer and release  it22,23. 
Understanding the balance between these bound and release states could help explain differences in functionality 
of WH2 domain containing proteins and identify key points of actin nucleation regulation.
In this study we have used mass spectrometry to analyse yeast Las17/WASP and have mapped phosphoryla-
tion sites including one at residue Ser554 within the WH2 domain. Functional analysis reveals changes in G-actin 
binding affinity attributable to this phosphorylation event. In cells a phospho-mimetic mutation (S554D) causes 
defects during the invagination and scission stages of endocytosis while, the non-phosphorylatable S554A muta-
tion causes a strong defect at an earlier endocytic stage. Together the data indicate the importance of this WH2 
motif residue for switching actin binding affinity of Las17 during distinct stages of endocytosis and might shed 
light on the functional variation across the spectrum of proteins carrying WH2 domains.
Results
Las17 can be phosphorylated in the WH2 domain. Yeast Las17, tagged with 3xHA epitope, was 
immunoprecipitated from extracts, isolated from gels and following tryptic digest, analysed by liquid chroma-
tography tandem mass spectrometry (LC–MS/MS). Two approaches were employed during the analysis, multi-
dimensional protein identification technology (MudPIT) and neutral loss multi stage activation (MSA). Phos-
phorylation site localization probabilities for all peptide match spectra were calculated using the phosphoRS 
algorithm. Figure 1A depicts phosphorylation sites (and their probabilities) identified using this analysis. Two of 
these sites S586 and S588 have been previously  reported24. A number of these sites lie in the C-terminal region of 
the protein with T543 just upstream of the WH2, while S554 lies within the predicted N-terminal helix forming 
region of the WH2 domain. The serine 554 residue is immediately upstream of the highly conserved isoleucine 
(I555 in Las17) which has previously been demonstrated to be key to actin binding (Fig. 1B). Analysis of the 
WH2 consensus sequence based on 43 seed sequences in the Pfam database (Fig. 1C) reveals only a limited range 
of residues at the position immediately upstream (− 1) of the conserved isoleucine. These residues are alanine, 
serine, glutamine, aspartate and glutamate. Phosphorylation at serine 554 in Las17 gives the possibility to switch 
from a small uncharged amino acid to an acidic, charged residue, thus potentially mimicking the difference 
between some of the residues most often found at this position. Other phosphorylation sites indicated by mass 
spectrometry were S586, S588 and S605. These lie within the less well conserved region between the WH2 and 
acidic region which, in other WASP proteins, has been associated with regulating  autoinhibition3,16,17. Given the 
lack of apparent auto-inhibition in yeast Las17, and the known importance of WH2 G-actin binding, this study 
focused on understanding the role of S554 phosphorylation.
Figure 1.  Phosphorylation of Las17 and impact on WH2 actin binding. (A) Mass spectrometry analysis 
revealed phosphorylated Las17 peptides. Most likely sites of modification indicated by phosphoRS analysis 
are indicated on Las17 schematic. (B) Alignment of WH2 domains from WASP family proteins from humans 
(h.s NP_000368); Danio rerio (NP_956232.1) Human N-WASP (BAA20128.1), Drosophila melanogaster 
WASP (NP_651637.1) Schizosaccharomyces pombe Wsp1 (AAB92587) and Saccharomyces cerevisiae Las17/
WASP (CAA99390). Arrow indicates Serine 554—phosphorylated in S. cerevisiae Las17. (C) WH2 consensus 
generated using WebLOGO indicating relative frequency of specific amino acids at certain sites in a consensus 
generated from 43 WH2 seed sequences listed on the Pfam database. Arrow indicates position equivalent to 
S554 in Las17 (D) Thermophoresis trace to measure G-actin binding affinity of wild type, phosphorylated and 
mutant WH2 peptides. Peptides corresponding to amino acids 541 to 569 were used in MST to show binding 
to 50 nM labelled actin. The assays were carried out in G-buffer plus 0.05% tween-20. (E) The pdb structure 
(3MN5) of the 4th WH2 domain of Spire was used to model Las17 WH2 domain bound to yeast actin with and 
without a serine phosphorylation modelled at Ser554 (upper panels). Lower panels show an expanded view of 
the interfacial region between actin subdomain 3 and the Spire WH2 domain peptide. Orientation is changed 
(denoted by arrow) in order to show the steric clashes that are imposed by phosphorylation at S554 (red). Pair-
wise overlap of atomic Van der Waals radii as predicted by PyMOL. The discs range in colour from green (slight 
overlap) to red (major overlap). Actin residues that are indicated with steric clashes T351 and L349 (equivalent 
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Phosphorylation of S554 reduces WH2 affinity for actin. In order to understand the impact of WH2 
phosphorylation at Ser554 on G-actin binding, peptides were synthesized (Las17 amino acids 541–569) and 
incubated with labelled G-actin. Binding affinity was analysed using microscale thermophoresis (MST). As 
shown in Fig. 1D, phosphorylation of the WH2 peptide significantly reduced its affinity for G-actin with calcu-
lated affinity reducing from 34 to 8000 nM.
To understand why phosphorylation is having such a profound effect, we modelled serine phosphorylation 
in the Las17 WH2 domain using the existing PDB structure of the fourth WH2 peptide of the actin-binding 
protein Spire in complex with actin. As shown in Fig. 1E, the addition of a phosphate group on the serine is likely 
to introduce steric hindrance between the WH2 helix and actin subdomain 3 and would therefore be unlikely 
to form an effective binding site.
In order to undertake studies in cells, mutations of the serine were generated, switching to the commonly 
used alternative residues of alanine to generate a non-phosphorylatable mutant, and aspartate to generate a 
phospho-mimetic residue. To facilitate subsequent interpretation of in vivo data we first undertook initial binding 
analyses of S554A and S554D mutant peptides using MST (Fig. 1D). The mutation S554D which introduced an 
acidic residue, reduced G-actin binding affinity (wt 34 nM; S554D 472 nM). This reduction in affinity of about 
tenfold, was not as great as observed in the phosphorylated peptide but given the smaller size and charge of 
aspartate relative to the phosphorylated serine this would be expected. Modelling of the WH2-actin interaction 
for the mutations is shown in Supplementary figure S1 and demonstrates some steric clash for the S554D but not 
the S554A mutation. Intriguingly, the S554A mutation also had a marked effect on binding affinity causing an 
increase in affinity to 7.0 nM. Thus, the S554A mutation, while it does prevent phosphorylation is not a simple 
equivalent to a non-phosphorylated residue. However, given the observed frequency of alanine at the − 1 position 
relative to the conserved isoleucine in WH2 domains (Fig. 1C), we reasoned that this mutant would allow us to 
investigate the impact of WH2 higher affinity actin binding further.
S554 mutants affect actin polymerization in vitro. Given the marked changes in affinity for the WH2 
peptides and G-actin, we next investigated the impact of these amino acid substitutions on actin polymerisation 
in vitro using incorporation of pyrene-labelled actin as a marker of filament formation. Given our hypothesized 
function of Las17-mediated actin nucleation in generating filaments de novo, assays were performed with rela-
tively low levels of actin and Las17. Under these conditions, the S554A mutant showed a significant increase in 
the rate of nucleation (a decrease in lag phase) compared to the S554D or wild type Las17 (Fig. 2A).
Following Las17-mediated generation of actin filaments de novo, we have proposed that Arp2/3 can then bind 
to these mother filaments and drive further actin nucleation and filament growth. We therefore also analysed 
the effect of the S554A and S554D mutants in the presence of Arp2/3. As shown in Fig. 2b, the mutants had a 
different effect. While the S554A still reduced the lag phase, the S554D mutant showed an enhanced elongation 
rate possibly because its lower affinity permits more rapid release of actin and its incorporation into filaments.
Figure 2.  The effect of Las17 S554 mutations on actin polymerization in vitro. 0.5 µM 5% pyrene labelled actin 
was polymerized in the presence of G-buffer plus 0.5 × KME as described in the absence (A) or presence (B) of 
5 nM Arp2/3. The effect of a Las17 fragment (amino acids 300–633) either wild-type or with an S554A or S554D 
mutation was investigated. Experiments were repeated at least three times and representative traces are shown. 
Analysis of significant differences was carried out using Uncorrected Dunn’s test and showed that in the absence 
of Arp2/3 the lag phase for nucleation by S554A is significantly reduced to about 40% of wt and S554D Las17 
lag phase times (p = 0.0447, and 0.0180 respectively). In the presence of Arp2/3 the lag phase for nucleation with 
S554A is reduced compared to that of wt (p = 0.0153) There is no significant difference between the lengths of 
the lag phases for S554A and S554D.
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The effect of Las17 S554 mutants on actin function in vivo. In order to investigate the physiological 
role of phosphorylation within the WH2 domain of Las17 in S. cerevisiae the S554A and S554D mutations were 
generated at the LAS17 locus in the genome. Expression of both mutants rescued the temperature sensitivity of 
the las17 deletion indicating at least partial functionality (Supplementary Fig. S2). Rhodamine-phalloidin stain-
ing to visualize F-actin revealed that both Las17 mutants rescued the large aggregates of actin observed in the 
las17 deletion strain though the S554A mutation appeared to cause a reduction in the polarised spatial distribu-
tion of actin patches in cells (Supplementary Fig. S2).
GFP-tagged versions of the Las17 mutants were made in the genome. As shown in Fig. 3A, B both mutations 
caused an increase in the lifetime of Las17 at the plasma membrane compared to the wild-type tagged protein 
indicating that both phosphorylated and dephosphorylated states may have roles at stages of the endocytic 
process. Given actin affinity changes, we reasoned if the S554D mutation reduced binding markedly in vivo 
then it could potentially resemble mutants with a complete loss of the WCA region. To test this, a GFP tagged 
Las17∆WCA mutant was generated and its lifetime analysed. As shown, this truncation mutant has a very 
similar lifetime to the Las17 S554D mutation. Coupled with analysis of the behavior of both Las17∆WCA and 
of the G-actin non-binding I555D  mutant25, this supports the idea that phosphorylation potentially acts to also 
reduce G-actin binding in vivo.
The effect of the S554 mutations on individual endocytic events. The increased lifetime of Las17 
mutants at the plasma membrane suggested there would be defects during endocytic progression. We therefore 
investigated the effect of the S554A and S554D mutations on the assembly of two reporters at endocytic sites. 
These were Sla1 a component of the late endocytic coat which, in wild-type cells, localizes at the same time as 
Las17, and Arc15 a subunit of the Arp2/3 complex which is usually recruited to sites about 10 s after Las17. The 
in vitro data demonstrated that the S554A mutant reduces the lag phase, indicative of a greater F-actin nuclea-
tion rate in the absence of Arp2/3 which might be expected to impact on all stages of actin function in endocyto-
sis while the phosphomimetic mutant S554D might be predicted to have an lesser impact due to other proteins 
also functioning in recruitment of G-actin at the sites.
Figure 3.  The effect of Las17S554 mutations on Las17-GFP in vivo. Wild type or mutant Las17 was tagged 
in the genome with a 7 × alanine linker and GFP and visualized as described. (A) Representative kymographs 
showing Las17-GFP. Vertical axis = distance from membrane, horizontal axis = time. (B) Lifetimes of patches 
were measured (combined data from from ≥ 3 experiments ≥ 5 cells on each occasion; n = 112 wt, n = 78 S554D, 
n = 67 S554A, n = 62 las17∆WCA). One way ANOVA with Dunnetts multiple comparison test indicates that 
all mutants show a significantly longer lifetime than the wild type protein n (p < 0.0001 in all cases). The 
Las17S554D and Las17∆WCA mutants.
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Figure 4.  The effect of Las17S554 mutations on individual endocytic events. (A) Representative kymographs 
from the bud circumference of cells expressing wild-type or Las17S554A/D mutants tagged with Sla1-GFP 
(green) and Arc15 (red). As individual kymographs are from endocytic patches whole surface of the cell 
invaginations are shown by movement in either direction on the x axis, and retractions are characterised by 
a subsequent change in direction on the x axis. Arrows indicate retraction events. (B) Lifetimes of Sla1 and 
Arc15 labelled patches in wild type and mutant cells. Green indicates time of only Sla1-GFP in the patch; 
yellow when both Sla1 and Arc15 are present and red the time when only Arc15 is observed. Error bars show 
standard deviation for each lifetime. Sla1-GFP and Arc15-ChFP patch lifetimes are significantly different for 
both mutants compared with the wild-type judged by one way ANOVA with Dunnetts multiple comparison test 
(p < 0.0001) (C) Patch tracking was also used to analyse the behavior of individual endocytic patches labelled 
with Sla1-GFP. Green dots represent the start of tracks and are on the membrane, red dots represent the ends 
of tracks. Movement in the plane of the membrane is represented on the x axis, y axis represents movement 
perpendicular to the plane of the membrane. The proportion of events measured from movies where retraction 
is observed are noted to the right of the images. n = 76 wt; n = 58 S554D; n = 60 S554A. (D) GFP-Abp1 was used 
to determine whether there was an overall impact of the mutations on the level of F-actin at endocytic sites over 
their lifetime. Dotted line shows mean; violin plots shows total distribution of intensity data. One way ANOVA 
with Dunnetts test indicates the S554D mutant causes a significantly lower recruitment of GFP-Abp1 while the 
S554A mutant causes a significant increase in GFP-Abp1 at individual endocytic sites (p < 0.0001 denoted ****).
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As shown in Fig. 4A,B, both mutations cause an increase in Sla1 lifetime prior to Arc15 recruitment. The effect 
on overall lifetime of the S554A mutation is markedly more pronounced than S554D with a long delay before 
Arc15 recruitment and also a much longer lifetime of Arc15. Analysis of labelled patches reveals behavioural dif-
ferences in the different mutants (Fig. 4A,C). As expected the wild type patches show relatively uniform behavior 
with Sla1 recruitment preceding Arc15 arrival, followed almost immediately by an invagination movement. In 
the presence of the Las17 S554D mutant while there was an increase in Sla1 lifetime before Arc15 recruitment, 
the most striking change was during invagination when there was an increase in the number of failed scission 
events. Rather than invagination being followed by an abrupt disassembly of factors from sites (as in wild type 
cells) the invagination appears to persist or retract back towards the membrane (Fig. 4A, arrowheads and 4C). 
In the presence of the higher affinity binding S554A mutant the clearest impact was on the lifetime of Sla1 prior 
to Arc15 recruitment which was nearly three times longer than that measured in wild type cells. Invaginations 
were often shallow but retraction and other failed scission events were also observed (arrows).
To address whether the S554 mutations led to an altered level of F-actin at endocytic sites, we analysed the 
recruitment and intensity of Abp1-GFP signal at sites. Abp1 is an actin binding protein that requires F-actin in 
order to localize to  sites26. As shown, in the accompanying movies and figure (Supplementary information and 
Supplementary Fig. 3), the lifetime of Abp1-GFP at endocytic sites reflects the same pattern as for Arc15, with 
elevated life times of localization for the mutants, especially for the S554A mutant. Both the mean and maximum 
intensity of patches were analysed to assess whether the level of F-actin at sites was increased. As shown (Fig. 4D), 
expression of the Las17 S554A mutant led to an increase in the overall mean level of F-actin at endocytic sites, 
though there was also a marked level of variation in patch intensity. Conversely, the phosphomimetic mutant 
that reduces affinity for G-actin has a lower level of F-actin at sites, supporting the idea that G-actin binding by 
WH2 contributes to overall recruitment of actin to endocytic sites.
Together the data demonstrates a role for phospho-regulation of Las17/WASP underpinning key stages of 
endocytosis. Many kinases have been associated with endocytic function in yeast but because endocytic events 
occur asynchronously in cells and, because kinases often function in sequence, co-dependently or redundantly 
it is difficult to determine impacts of specific single modification events using population based approaches 
such as mass spectrometry or gel analysis of Las17 from cells. In order to remove some of these complexities 
we generated a reporter peptide of Las17 amino acids 500–581 carrying a mutation at T543A, the only other 
phosphorylation site clearly identified in this region (Fig. 1A). This reporter, as well as one additionally mutated 
at S554A (T*S*) was expressed in cells. While the T*S reporter runs at a higher molecular weight than the T*S* 
double mutant indicating that phosphorylation of the fragment can occur in cells, analysis of the reporter in 
single kinase deletions of (yak1, yck1, yck2, ark1, prk1, and pho85) and double kinase deletions (ark1∆,prk1∆; 
yck1∆yck2ts) in our hands revealed no inhibition of S554 phosphorylation.
Discussion
While phosphorylation of WASP family members has been reported to influence function, this is the first report 
of a regulatory phosphorylation event within the actin-binding WH2  domain15–17,27. The dramatic shift in actin 
binding affinity on phosphorylation of the serine within the WH2 N-terminal helix region of Las17 is substantial 
and may in part explain the breadth of functions associated with WH2 domains in proteins. Three major find-
ings are reported in this study: 1 an acidic residue at this site in WH2 reduces affinity for actin, reduces actin 
levels at endocytic sites and impacts on success of scission events. 2. an alanine residue at this site has higher 
actin binding affinity but delays early stages of endocytic progression. 3. phosphorylation of serine adjacent to 
the conserved isoleucine in the alpha helix of the WH2 domain in Las17 significantly reduces actin binding. 
Together the data suggest that switching of Las17 phosphorylation states may allow progression through distinct 
phases of endocytosis from site assembly through to the final scission stage.
In yeast, Las17 arrives at plasma membrane sites about 15 s prior to the well-studied nucleating complex 
Arp2/3 and before the only other WH2 domain containing protein  Vrp128–30. We have previously proposed that 
Las17 alone is capable and responsible for generating mother filaments de novo at endocytic  sites25,31.
The S554 mutants had clear phenotypic differences when expressed in cells. For S554D a reduced ability to 
recruit G-actin is reflected in the lower intensity of F-actin at endocytic sites. This lower level of F-actin did not 
however appear to be strongly inhibitory during the initial or invagination stages of endocytosis though intrigu-
ingly, the scission stage of endocytosis did appear to be significantly defective with the majority of invaginations 
showing failed scission. Fitting with previous  data25 this suggests that regions of Las17 other than WH2 are key 
to recruitment of actin at early stages of endocytosis. This Arp2/3-independent activity leads to generation of 
F-actin sufficient to then recruit Arp2/3 and other actin binding proteins such as Vrp1and the type I myosins. In 
turn this facilitates membrane invagination, with the reduced actin binding affinity of S554D/phosphorylation 
potentially beneficial to facilitate the rapid growth of Arp2/3 generated actin filaments. The scission defect is 
particularly interesting and suggests that WH2 dephosphorylation is required to meet an additional requirement 
for actin recruitment, possibly for further filament nucleation or to facilitate tension generation, to complete 
vesicle scission. A possible role for actin during vesicle scission has been suggested from electron microscopy 
studies which have detected Las17 localization mid-way down invaginations prior to scission and from an 
analysis of yeast dynamin function and in studies linking dynamin/Vps1 vesicle scission with actin  function29,32.
The phenotype of the S554A mutation is more severe and highlights potential impacts of non-phosphoryl-
atable mutations sometimes causing distinct phenotypes themselves. However the prevalence of alanine at this 
specific position in the N-terminal helix of a significant number of WH2 domains meant that there was value in 
determining the effect of such a mutation within a physiological system. Despite the S554A mutation enhanc-
ing actin binding affinity and actin nucleation in vitro, the in vivo impact was to markedly inhibit the endocytic 
process both by delayed recruitment of Arp2/3 and of the inhibition of the subsequent invagination stage. It 
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is possible that the increased actin affinity means that Las17 remains associated with the nascent filament for 
longer and thereby precludes effective recruitment of Arp2/3. Alternatively, there could be increased F-actin 
polymerization at endocytic sites but this actin might be structured or organized in such a way that appropriate 
levels of Arp2/3 to drive invagination are not recruited.
Thus within the context of yeast, we hypothesize that phosphorylation at Ser554 may provide a regulatory 
switch between a phosphorylated weak binding state that favours Arp2/3-dependent nucleation during invagina-
tion to a stronger (though still polar, serine residue) binding that more effectively supports Arp2/3-independent 
nucleation that functions at initial and final stages of the process.
In terms of broader implications of this study, we have analysed other WH2 domains and note that there is a 
restricted number of residues that occupy the position -1 to the highly conserved isoleucine in the N-terminal 
WH2 helix (Fig. 1C). Our in vitro binding data and that from yeast would indicate that the nature of this residue 
has very marked implications for the function of the protein in which it resides. Those proteins with alanine at 
the site may bind G-actin more strongly and, if there are tandem similar domains this might be critical to allow 
a stable nucleus to be formed and for new filaments to be formed. In contrast proteins that harbor an acidic 
residue at this site are likely to have weaker binding. Such activity might be less effective for forming a nucleus 
but might be more optimal to support rapid filament growth as the monomer are likely to be released more 
readily into filaments. Supporting this idea, Cobl which is viewed as a strong nucleator, has three tandem actin-
binding WH2  domains13. All of these have alanine at the site adjacent to the isoleucine. Spire on the other hand 
which has a weaker nucleating activity has Glu, Asp, Phe and Ser at its predicted WH2  domains9,11. The only 
other protein in S. cerevisiae with WH2 domains is verprolin (Vrp1), which is proposed to function only in the 
invagination, stages of endocytosis concomitant with Arp2/3 activity. The two Vrp1 WH2 domains both contain 
Asp at the position adjacent to the conserved isoleucine supporting the idea that reduced affinity is associated 
with enhanced activity in the presence of Arp2/3.
Overall this study reveals the possibility of a phosphorylation mediated regulation of yeast WASP function 
to support distinct stages of endocytosis. It also more broadly highlights the importance of a key residue within 
WH2 domains that might allow more general prediction of the activity of a actin binding protein.
Methods
Chemicals and media were obtained from Sigma-Aldrich, Fisher Scientific, or Formedium.
Yeast growth and strain generation. Yeast strains used in this study are listed in supplemental Table 1. 
Yeast plasmids used: pKA88 carrying GFP tagged  Abp126, pKA606 carrying wild type  Las1725; mutations in 
pKA606: pKA1087 with Las17 S554A and pKA1088 with S554D. Unless stated otherwise, cells were grown with 
rotary shaking at 30 °C in liquid YPD medium (1% yeast extract, 2% Bacto-peptone, 2% glucose supplemented 
with 40 μg/ml adenine) or in synthetic medium (0.67% yeast nitrogen base, 2% glucose) with appropriate sup-
plements. All strains carrying fluorescent tags have growth properties similar to control strains. Point mutations 
in LAS17 were generated using site directed mutagenesis (Agilent). DNA cassettes carrying mutations for inte-
gration were transformed into KAY1801. Mutant colonies were counter-selected on minimal medium, contain-
ing 0.005% uracil and 0.1% 5’-Fluoroorotic Acid (5-FOA; Melford laboratories). Allele exchange, in growing 
Ura3-5-FOA resistant colonies, was confirmed by PCR and sequencing.
Fluorescence microscopy. For live-cell imaging, cells expressing tagged proteins were visualized after 
growing to an early log phase. Analysis was carried out at room temperature (22 °C). Imaging of GFP-tagged 
Sla1 and Abp1 proteins expressed singly was performed with 0.5 s exposure and 1 s time-lapse. Sla1-GFP and 
Arc15-mCherry co-localisation was performed with 0.5 s exposure for both fluorophores, and 2 s time-lapse. 
Microscopy used Olympus IX-81 inverted microscope with DeltaVision RT Restoration Microscopy System 
(100 × /1.40 NA oil objective), Photometrics Coolsnap HQ camera and Image capture performed using Soft-
WoRx image analysis and model-building application (Applied Precision Instruments, Seattle). All image data 
sets were deconvolved using the SoftWoRx application. Time-lapse of wild-type and mutated Las17-GFP was 
acquired using OMX DeltaVision V4 and a 60 × /1.42 NA objective. Images were taken simultaneously on sepa-
rate scientific complementary metal oxide semiconductor (sCMOS) cameras (30 ms exposure). Seven 250 nm 
sections were acquired every 0.5 s (241 time points). The stacks were then deconvolved and processed, using 
SoftWorx. Protein localisation and lifetime was analysed from those projections. Fiji software was used to assem-
ble movies and kymographs, to determine GFP-Abp1 patches intensity and area, and for individual spots track-
ing. Statistical analysis of lifetimes, patches intensity and area was performed using Graphpad Prism software.
Protein purification and assays. Las17 fragments were expressed as GST fusion proteins as described 
 previously25. Briefly plasmids were transformed into Lucigen OverExpress C41(DE3) cells and transformants 
selected on an agar plate containing ampicillin. Transformed colonies were grown in 2 L of 2xYT medium for 
5 h or until mid-log phase. The cell cultures were then induced with 1 mM IPTG for 5 h. Pelleted cells were 
then frozen at − 20 °C until use. To purify the expressed protein cells were thawed in PBS containing protease 
inhibitors (Roche complete inhibitor cocktail) and 2 mM DTT. Cells were broken by sonication for 3 × 30 s on 
ice, and cell debris pelleted by centrifugation at 20,000 × g for 30 min. The supernatant was then supplemented 
with an additional 300 mM NaCl and mixed with 100 µl of Glutathione Sepharose beads which had been pre-
equilibrated with buffer A (PBS plus an additional 300 mM NaCl). GST tagged protein was allowed to bind for 
30 min at 4 °C with rotation. Unbound protein was then washed from the beads by a series of washes of 3 × 15 ml 
each of buffer B (buffer A plus 0.1% Tween), and then 3 × 15 ml PBS. Washed beads were then equilibrated in 
Prescission protease cleavage buffer (50 mM Tris–HCl, pH 7.0 (at 25 °C), 150 mM NaCl, 1 mM EDTA, 1 mM 
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dithiothreitol). Las17 protein was cleaved from the GST tag by incubation with 10units of Prescission Protease 
for 6 h at 4 °C. Cleaved Las17 was buffer exchanged into G-buffer (2 mM Tris pH 8.0, 0.2 mM CaCl2, 0.2 mM 
ATP, 0.5 mM DTT) using a PD10 buffer exchange column and frozen in aliquots until required. Protein concen-
tration was determined by comparison with a known protein standard on SDS PAGE.
Peptides used, Las17(501–528), were synthesized by Pi Proteomics (Huntsville, AL). Rabbit skeletal muscle 
actin was purified and gel filtered as  described31. Briefly, acetone powder (5 g) prepared from fresh rabbit leg 
muscle was hydrated in G-buffer for 30 min, spun and filtered through glass wool and 0.2 µM filters, and then 
polymerised by the addition of KCl and  MgCl2 for 30 min at room temperature followed by 30 min a 4 °C with 
gentle stirring. Polymerised actin was pelleted by centrifugation at 34,900 × g for 2 h before being resuspended in 
G-buffer and dialysed against G-buffer for 48 h to depolymerise with buffer changes twice daily. Finally mono-
meric actin was separated from dimers and short oligomers by gel filtration in a 1 m x 26 mm sephadex column 
in G-buffer. Peak and post-peak actin fractions containing actin monomers were stored at 4 °C for up to two 
weeks. Pre-peak actin fractions were pooled, dialysed against G-buffer without DTT, and made to 20uM before 
being polymerised by the addition of 100 mM KCl, 2 mM  MgCl2. Pyrene (4 mg dissolved in 400 µl DMSO) was 
added to the F-actin and stirred overnight to allow binding. The pyrene actin was then depolymerised by dialysis 
against G-buffer and unbound pyrene was removed by gel filtration in a 1000 mm × 26 mm sephadex column. 
Pyrene incorporation was determined by measuring absorbance at 290 nm and 344 nm.
For fluorimetry assays, 370 μl assays used 0.5 μM actin. Pyrene-actin was added to 5%, mixed thoroughly, 
and added to the fluorimetry cuvette. Polymerization salts, 10 × KME (500 mM KCL, 10 mM  MgCl2, 10 mM 
EGTA, 100 mM Tris–HCl [pH 8.0]) were used at final concentration of 0.5 × KME before reading fluorescence. 
Polymerization was observed in a Cary Eclipse fluorometer (emission 364 nm, slit 10 nm round; excitation 
385 nm, slit 20 nm) as described  previously31. Unless otherwise stated Las17 fragments were used at 25 nM and 
Arp2/3 (obtained from Cytoskeleton Inc, USA) at 2 nM.
Microscale Thermophoresis (MST) was used to measure binding affinities with actin as previously  described31. 
Briefly, rabbit muscle actin in G-buffer without DTT was labelled using a Monolith NT™ protein labelling kit 
RED-Malemide (NanoTemper Technologies, Munich, Germany). Las17 was prepared as two-fold serial dilu-
tions and an equal volume of labelled actin was added to each reaction (Final buffer conditions: G-buffer + 0.05% 
Tween). Each reaction was then loaded into Monolith NT.115 Premium Treated Capillaries (NanoTemper 
Technologies) and thermophoresis was measured in a Monolith NT.115 Microscale Thermophoresis device 
(NanoTemper Technologies). Thermophoresis was measured at 20% red LED power and 40% IR laser power 
at 22 °C. The Fnorm was calculated from the ratio of fluorescence before heating and after the new equilibrium 
had been reached. Fnorm was then plotted against Las17 concentration to give the Las17 dependent change in 
thermophoresis. This was described by the ‘Kd fit’ model on the provided software to give Kds for actin binding 
to Las17 fragments.
Analysis of Phosphorylation of S554 in vivo. A Las17 gene fragment encompassing sequence for amino 
acids 500–581 was cloned into a vector pKA526 (pTPI1-mcs-3xHA) at BamH1 and Sal1 sites to allow generation 
of Las17(500–581) with a 3 × HA tag. To facilitate analysis of phosphorylation of only the S554 phosphorylation 
event, the T543 residue was mutagenized to alanine, using a QuikChange mutagenesis kit and appropriate oli-
gonucleotides, generating pKA1264. Mutagenesis was verified by sequencing. A further reporter with S554 also 
mutagenized to alanine was also created (pKA1266). The plasmids were transformed into wild type or strains 
harbouring deletions of various kinases that have been associated with endocytosis. Strains carrying plasmids 
were selected and grown to log phase. 5 ml cells were broken in lysis buffer in the presence of protease and phos-
phatase inhibitors (50 mM Tris–HCl pH 7.5, 100 mM NaCl, 0.1% Triton X-100, 0.1% β-mercaptoethanol, 1 mM 
EGTA, 2.5 mM EDTA, 1 mM PMSF, protease inhibitor cocktail without EDTA [Roche], 10 μM Leupeptin, 1 μM 
Pepstatin-A, PhosSTOP cocktail [Roche], 1 mM NaF, 0.5 mM  Na3VO4 ) using small scale bead-beating. EZ view 
red anti-HA agorose beads (Merck) were added to the supernatant and incubated overnight at 4 °C with rota-
tion. Beads were washed with lysis buffer, then resuspended in 2 × gel sample buffer and boiled. Proteins were 
separated using SDS-PAGE (15% polyacrylamide) in the presence of 200 µM PhosTag (Alpha labs) and blotted 
onto membrane. Membranes were probed with anti-HA antibodies (rat; Sigma Aldrich).
Structural modelling. Las17 residues 546–567 (WH2 domain) were structurally modelled using the  4th 
WH2 domain of Spire obtained from an actin-bound structure (pdb 3MN5). Structural modelling was carried 
out using the homology-modelling server found on the SWISS-MODEL website (https:// swiss model. expasy. 
org/) which gave an acceptable  QMEAN33–37. Amino acid substitution to phosphoserine was achieved using 
the SwissSidechain PyMOL plugin (v2)38. The mutagenesis wizard tool in PyMOL (version 2.4.1) was used to 
suggest how residue substitutions within the WH2 domain may result in spatial clashing with actin  residues39.
Data availability
The majority of data generated or analysed during this study are included in this published article (and its Sup-
plementary Information files).
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